Get the Stockscreener App
12.91
0.98%
0.1251
Overview
News
Price History
Option Chain
Why RDY Down?
Discussions
Forecast
Stock Split
Dividend History
Dr Reddys Laboratories Ltd Adr stock is traded at $12.91, with a volume of 289.78K.
It is up +0.98% in the last 24 hours and down -5.18% over the past month.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
See More
Previous Close:
$12.78
Open:
$12.83
24h Volume:
289.78K
Relative Volume:
0.17
Market Cap:
$2.14B
Revenue:
$3.47B
Net Income/Loss:
$668.83M
P/E Ratio:
3.2161
EPS:
4.0127
Net Cash Flow:
$253.46M
1W Performance:
-4.34%
1M Performance:
-5.18%
6M Performance:
-20.44%
1Y Performance:
-13.76%
1-Day Range:
$12.81
$12.92
1-Week Range:
$12.62
$13.20
52-Week Range:
$12.62
$16.89
Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile
Compare RDY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RDY
Dr Reddys Laboratories Ltd Adr
|
12.90 | 2.14B | 3.47B | 668.83M | 253.46M | 4.0127 |
|
ZTS
Zoetis Inc
|
168.92 | 75.15B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.62 | 47.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.70B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.28 | 18.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.27 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Downgrade | Nomura | Buy → Neutral |
| Jan-11-24 | Downgrade | Jefferies | Buy → Underperform |
| Aug-29-23 | Downgrade | HSBC Securities | Buy → Hold |
| May-18-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-17-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-30-23 | Initiated | JP Morgan | Underweight |
| Nov-14-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Jan-03-22 | Resumed | BofA Securities | Neutral |
| Jul-27-21 | Downgrade | Credit Suisse | Outperform → Neutral |
| Feb-02-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Sep-18-20 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-18-20 | Upgrade | Investec | Sell → Hold |
| Jan-28-20 | Downgrade | CLSA | Buy → Outperform |
| Jan-27-20 | Downgrade | CLSA | Buy → Outperform |
| Jan-09-20 | Upgrade | Citigroup | Sell → Buy |
| Nov-04-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Sep-04-19 | Upgrade | Credit Suisse | Underperform → Outperform |
| Jul-01-19 | Upgrade | Macquarie | Neutral → Outperform |
| Jun-20-19 | Initiated | Deutsche Bank | Hold |
| Jun-11-19 | Initiated | Barclays | Equal Weight |
| May-20-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Feb-19-19 | Upgrade | CLSA | Outperform → Buy |
| Jan-17-19 | Downgrade | Citigroup | Neutral → Sell |
| Sep-21-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-31-17 | Upgrade | CLSA | Underperform → Outperform |
| Jul-28-17 | Downgrade | CLSA | Underperform → Sell |
| Jul-27-16 | Downgrade | HSBC Securities | Hold → Reduce |
| Jul-27-16 | Downgrade | Jefferies | Hold → Underperform |
| Feb-10-16 | Upgrade | Credit Agricole | Underperform → Buy |
| Nov-10-15 | Downgrade | Citigroup | Buy → Neutral |
View All
Dr Reddys Laboratories Ltd Adr Stock (RDY) Latest News
Dr. Reddy's Laboratories Ltd. Sponsored ADR to Host Earnings Call - ACCESS Newswire
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Asian Equities Traded in the US as American Depositary Receipts Tumble in Monday Trading - TradingView
Alvotech heldur kynningarfund fyrir fjárfesta 27. mars 2025, eftir birtingu uppgjörs fyrir árið 2024 og fjórða ársfjórðung - GlobeNewswire Inc.
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading, Up 2.2% for Week - MSN
Its Stock Has Paid Off Big Time For Dr. Reddy’s Laboratories Ltd. ADR - SETE News
Marshall Wace, DE Shaw, Millennium Helped Drive China ADR Surges - Mint
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading; End Week Up 2% - TradingView
Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - TradingView
Zacks Research Issues Pessimistic Forecast for RDY Earnings - MarketBeat
Indian ADRs Alert! Why Infosys, Wipro, HDFC Bank, ICICI Bank, Dr Reddy's Lab Will Be In Focus On February 13? - Goodreturns
Taking on analysts’ expectations and winning: Dr. Reddy’s Laboratories Ltd. ADR (RDY) - SETE News
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] Sees Decrease in Stock Value - Knox Daily
Nothing is Better Than Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) stock at the moment - SETE News
Ecolab, Inc (ECL) expanding its growth trajectory ahead - SETE News
A look into Golar Lng (GLNG)’s deeper side - SETE News
Altria Group Inc [NYSE: MO] Sees Increase in Stock Value - Knox Daily
Moody’s Corp [MCO] Shares Jump Approximately 26.66% Over the Year - Knox Daily
Understanding the 1.67% Volatility Levels of Dr. Reddy’s Laboratories Ltd. ADR’s (RDY) Stock in the Past 30 Days - The News Heater
LLY Stock Quote Price and Forecast - CNN
Dr. Reddy’s Faces GST Penalty, Evaluates Appeal - TipRanks
Asian Equities Traded in the US as ADRs Rise in Tuesday Trading - MSN
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold? - The Economic Times
Dr. Reddy’s Labs ADR earnings missed by $0.02, revenue fell short of estimates - Investing.com
Coupang Inc (NYSE: CPNG): A Blank Check? - Stocks Register
Q3 Results Updates: Indus Towers Profit Surges 159%; United Spirits Profit Falls 4% - NDTV Profit
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth - Moneycontrol
Week Ahead: Q3 Results, FII flow, Donald Trump inauguration, global cues among key market triggers for Sensex, Nifty - Mint
Wipro ADR rises 4% on NYSE after IT major’s net profit shoots 24% YoY to surpass Street estimates in Q3FY25 - Mint
Stock Market News Today highlights on January 16, 2025 : Stock exchanges ban fresh F&O positions in Kalyan Jewellers | Stock Market News - Mint
Dr. Reddy's Laboratories12 stocks trade against tide, hover near their 52-week high - The Economic Times
GAMMA Investing LLC Has $107,000 Position in Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World
Guess who’s the richest MLA in outgoing Delhi assembly? Hint – it’s NOT Kejriwal, Atishi or Sisodia | Mint - Mint
Dr Reddy Share Price Highlights : Dr Reddy closed today at ₹1374.1, up 1.73% from yesterday's ₹1350.75 | Stock Market News - Mint
Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Asian Equities Traded in the US as ADRs Rise in Thursday Trading - MSN
Buy Dr Reddy's & IRB Infra shares; sell JSW Energy stock, says YES Securities - Business Today
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading - MSN
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading - MSN
Where is Dr Reddy's Share Price Headed in 2025? - Equitymaster
Weekly Upgrades and Downgrades - InvestorPlace
Stock Market News Today Live Updates on December 20, 2024 : Top Gainers and Losers today on 20 December, 2024: Dr Reddys Laboratories, ICICI Bank, Tech Mahindra, Trent among most active stocks; Check full list here | Stock Market News - Mint
Dr Reddy’s shares jump over 4 per cent on upgrade by NomuraMarket News - The Financial Express
Zopiclone Market Forecast: Trends and Investment - openPR
Dr Reddy's Laboratories Share Price Live Updates: Disclosure Under Regulation 30 Of SEBI (LODR) Regulatio... - The Economic Times
Dr Reddy’s will top up base business with innovation in India: M V Ramana - BusinessLine
ADR, GDR Listings of Indian companies - Goodreturns
Asian Equities Traded in the US as American Depositary Receipts Edge Down in Wednesday Trading - MSN
NVO Stock Quote Price and Forecast - CNN
Dr Reddy's Labs tanks over 3% after USFDA inspects Hyderabad API facility - Business Standard
Stocks to watch on November 21: Adani Group stocks, Dr Reddy's, Godrej Properties, Tata Power, GRSE, UPL, Bharti Airtel - Upstox
Dr Reddys Laboratories Ltd Adr Stock (RDY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):